Real-world effectiveness of casirivimab and imdevimab among patients diagnosed with COVID-19 in the ambulatory setting: a retrospective cohort study using a large claims database
Hussein et al., BMJ Open, doi:10.1136/bmjopen-2022-064953
https://c19early.org/hussein2.html